{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:05:39Z","timestamp":1789693539266,"version":"4.0.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anaplastic thyroid cancer (ATC) is an aggressive endocrine malignancy characterized by rapid progression and limited therapeutic options. Ferritinophagy, a selective autophagic process mediated by NCOA4, regulates intracellular iron homeostasis. Here, we demonstrate that the prolyl isomerase Pin1 drives ATC progression by suppressing NCOA4-dependent ferritinophagy. Mechanistically, Pin1 recognizes phosphorylated NCOA4 through its substrate-binding WW domain. CDK2 phosphorylates NCOA4 at Ser572, creating a binding site for Pin1. This interaction promotes K29\/K48-linked polyubiquitination and proteasomal degradation of NCOA4, thereby blocking ferritinophagy, lowering intracellular Fe\u00b2\u207a and lipid peroxidation, and ultimately suppressing ferroptosis. Pin1 knockdown or treatment with the pharmacological Pin1 inhibitor KPT-6566 stabilizes NCOA4, enhances ferritinophagy, and triggers ferroptosis, markedly restraining ATC growth both in vitro and in vivo. These findings identify Pin1 as a previously unrecognized suppressor of ferroptosis through NCOA4-dependent ferritinophagy and support Pin1 inhibition as a potential therapeutic strategy for ATC.<\/jats:p>","DOI":"10.1038\/s41419-026-09058-5","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:37:28Z","timestamp":1782873448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pin1 targets phosphorylated NCOA4 for K29\/K48-linked ubiquitination to suppress ferritinophagy and ferroptosis in anaplastic thyroid cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5583-6599","authenticated-orcid":false,"given":"Zicheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-5812","authenticated-orcid":false,"given":"Hannah Xiaoyan","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-7732","authenticated-orcid":false,"given":"Weiming","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"9058_CR1","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388:2783\u201395.","journal-title":"Lancet"},{"key":"9058_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/790834","volume":"2014","author":"M Ragazzi","year":"2014","unstructured":"Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol. 2014;2014:790834.","journal-title":"Int J Endocrinol"},{"key":"9058_CR3","doi-asserted-by":"publisher","first-page":"E2083","DOI":"10.1002\/hed.24384","volume":"38","author":"SM Glaser","year":"2016","unstructured":"Glaser SM, Mandish SF, Gill BS, Balasubramani GK, Clump DA, Beriwal S. Anaplastic thyroid cancer: prognostic factors, patterns of care, and overall survival. Head Neck. 2016;38:E2083\u201390.","journal-title":"Head Neck"},{"key":"9058_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MED.0000000000000823","volume":"30","author":"S Hamidi","year":"2023","unstructured":"Hamidi S, Maniakas A. Recent advances in anaplastic thyroid cancer management. Curr Opin Endocrinol Diab Obes. 2023;30:259\u201364.","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"9058_CR5","doi-asserted-by":"publisher","first-page":"e70024","DOI":"10.1002\/mco2.70024","volume":"5","author":"S Qian","year":"2024","unstructured":"Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y, et al. Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets. MedComm. 2024;5:e70024.","journal-title":"MedComm"},{"key":"9058_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"9058_CR7","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"9058_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9:271.","journal-title":"Signal Transduct Target Ther"},{"key":"9058_CR9","doi-asserted-by":"publisher","first-page":"216152","DOI":"10.1016\/j.canlet.2023.216152","volume":"561","author":"S Zheng","year":"2023","unstructured":"Zheng S, Guan XY. Ferroptosis: promising approach for cancer and cancer immunotherapy. Cancer Lett. 2023;561:216152.","journal-title":"Cancer Lett"},{"key":"9058_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"9058_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116971","volume":"177","author":"Y Chen","year":"2024","unstructured":"Chen Y, Pan G, Wu F, Zhang Y, Li Y, Luo D. Ferroptosis in thyroid cancer: potential mechanisms, effective therapeutic targets and predictive biomarker. Biomed Pharmacother. 2024;177:116971.","journal-title":"Biomed Pharmacother"},{"key":"9058_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41580-020-00326-6","volume":"22","author":"S Alberti","year":"2021","unstructured":"Alberti S, Hyman AA. Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing. Nat Rev Mol Cell Biol. 2021;22:196\u2013213.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9058_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1043344","volume":"13","author":"K Sun","year":"2022","unstructured":"Sun K, Li C, Liao S, Yao X, Ouyang Y, Liu Y, et al. Ferritinophagy, a form of autophagic ferroptosis: new insights into cancer treatment. Front Pharmacol. 2022;13:1043344.","journal-title":"Front Pharmacol"},{"key":"9058_CR14","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425\u20138.","journal-title":"Autophagy"},{"key":"9058_CR15","doi-asserted-by":"crossref","unstructured":"Ohshima T, Yamamoto H, Sakamaki Y, Saito C, Mizushima N. NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy. J Cell Biol. 2022;221 (10).","DOI":"10.1083\/jcb.202203102"},{"key":"9058_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41388-020-01622-3","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Kong Y, Ma Y, Ni S, Wikerholmen T, Xi K, et al. Loss of COPZ1 induces NCOA4-mediated autophagy and ferroptosis in glioblastoma cell lines. Oncogene. 2021;40:1425\u201339.","journal-title":"Oncogene"},{"key":"9058_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-62026-4_4","volume":"1301","author":"N Santana-Codina","year":"2021","unstructured":"Santana-Codina N, Gikandi A, Mancias JD. The role of NCOA4-mediated ferritinophagy in ferroptosis. Adv Exp Med Biol. 2021;1301:41\u201357.","journal-title":"Adv Exp Med Biol"},{"key":"9058_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101154","volume":"77","author":"Z Liu","year":"2024","unstructured":"Liu Z, Liu C, Fan C, Li R, Zhang S, Liu J, et al. E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resist Updat. 2024;77:101154.","journal-title":"Drug Resist Updat"},{"key":"9058_CR19","doi-asserted-by":"crossref","unstructured":"Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X, et al. Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron-dependent HERC2-mediated proteolysis. Elife. 2015;4.","DOI":"10.7554\/eLife.10308"},{"key":"9058_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102451","volume":"56","author":"K Li","year":"2022","unstructured":"Li K, Chen B, Xu A, Shen J, Li K, Hao K, et al. TRIM7 modulates NCOA4-mediated ferritinophagy and ferroptosis in glioblastoma cells. Redox Biol. 2022;56:102451.","journal-title":"Redox Biol"},{"key":"9058_CR21","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1080\/15548627.2023.2170960","volume":"19","author":"H Wu","year":"2023","unstructured":"Wu H, Liu Q, Shan X, Gao W, Chen Q. ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4. Autophagy. 2023;19:2062\u201377.","journal-title":"Autophagy"},{"key":"9058_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106456","volume":"184","author":"W Wu","year":"2022","unstructured":"Wu W, Xue X, Chen Y, Zheng N, Wang J. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies. Pharm Res. 2022;184:106456.","journal-title":"Pharm Res"},{"key":"9058_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nrm2261","volume":"8","author":"KP Lu","year":"2007","unstructured":"Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol. 2007;8:904\u201316.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9058_CR24","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1158\/0008-5472.CAN-22-3407","volume":"83","author":"Z Sun","year":"2023","unstructured":"Sun Z, Jiang Q, Gao B, Zhang X, Bu L, Wang L, et al. AKT blocks SIK1-mediated repression of STAT3 to promote breast tumorigenesis. Cancer Res. 2023;83:1264\u201379.","journal-title":"Cancer Res"},{"key":"9058_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41418-023-01128-x","volume":"30","author":"J Chen","year":"2023","unstructured":"Chen J, Li M, Liu Y, Guan T, Yang X, Wen Y, et al. PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions. Cell Death Differ. 2023;30:1082\u201395.","journal-title":"Cell Death Differ"},{"key":"9058_CR26","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s12272-016-0821-x","volume":"39","author":"SH Min","year":"2016","unstructured":"Min SH, Zhou XZ, Lu KP. The role of Pin1 in the development and treatment of cancer. Arch Pharm Res. 2016;39:1609\u201320.","journal-title":"Arch Pharm Res"},{"key":"9058_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jare.2023.09.011","volume":"61","author":"J Tang","year":"2024","unstructured":"Tang J, Li J, Lian J, Huang Y, Zhang Y, Lu Y, et al. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer. J Adv Res. 2024;61:239\u201351.","journal-title":"J Adv Res"},{"key":"9058_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2018.11.035","volume":"48","author":"J Zhang","year":"2019","unstructured":"Zhang J, Chen M, Zhu Y, Dai X, Dang F, Ren J, et al. SPOP promotes nanog destruction to suppress stem cell traits and prostate cancer progression. Dev Cell. 2019;48:329\u201344.e5.","journal-title":"Dev Cell"},{"key":"9058_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9058_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"9058_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0903-0","volume":"17","author":"S Saini","year":"2018","unstructured":"Saini S, Tulla K, Maker AV, Burman KD, Prabhakar BS. Therapeutic advances in anaplastic thyroid cancer: a current perspective. Mol Cancer. 2018;17:154.","journal-title":"Mol Cancer"},{"key":"9058_CR32","doi-asserted-by":"publisher","first-page":"e80011","DOI":"10.1371\/journal.pone.0080011","volume":"8","author":"C Sun","year":"2013","unstructured":"Sun C, Li Q, Hu Z, He J, Li C, Li G, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China. PLoS One. 2013;8:e80011.","journal-title":"PLoS One"},{"key":"9058_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0844-y","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wu YR, Yang HY, Li XZ, Jie MM, Hu CJ, et al. Prolyl isomerase Pin1: a promoter of cancer and a target for therapy. Cell Death Dis. 2018;9:883.","journal-title":"Cell Death Dis"},{"key":"9058_CR34","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1021\/bi973060z","volume":"37","author":"M Schutkowski","year":"1998","unstructured":"Schutkowski M, Bernhardt A, Zhou XZ, Shen M, Reimer U, Rahfeld JU, et al. Role of phosphorylation in determining the backbone dynamics of the serine\/threonine-proline motif and Pin1 substrate recognition. Biochemistry. 1998;37:5566\u201375.","journal-title":"Biochemistry"},{"key":"9058_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/77929","volume":"7","author":"MA Verdecia","year":"2000","unstructured":"Verdecia MA, Bowman ME, Lu KP, Hunter T, Noel JP. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat Struct Biol. 2000;7:639\u201343.","journal-title":"Nat Struct Biol"},{"key":"9058_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/hsz-2017-0137","volume":"399","author":"A Matena","year":"2018","unstructured":"Matena A, Rehic E, H\u00f6nig D, Kamba B, Bayer P. Structure and function of the human parvulins Pin1 and Par14\/17. Biol Chem. 2018;399:101\u201325.","journal-title":"Biol Chem"},{"key":"9058_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0962-8924(02)02253-5","volume":"12","author":"KP Lu","year":"2002","unstructured":"Lu KP, Liou YC, Zhou XZ. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002;12:164\u201372.","journal-title":"Trends Cell Biol"},{"key":"9058_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ni.1697","volume":"10","author":"ZJ Shen","year":"2009","unstructured":"Shen ZJ, Esnault S, Schinzel A, Borner C, Malter JS. The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nat Immunol. 2009;10:257\u201365.","journal-title":"Nat Immunol"},{"key":"9058_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molcel.2009.06.013","volume":"35","author":"Y Zheng","year":"2009","unstructured":"Zheng Y, Xia Y, Hawke D, Halle M, Tremblay ML, Gao X, et al. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell. 2009;35:11\u201325.","journal-title":"Mol Cell"},{"key":"9058_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ncb1818","volume":"11","author":"TH Lee","year":"2009","unstructured":"Lee TH, Tun-Kyi A, Shi R, Lim J, Soohoo C, Finn G, et al. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol. 2009;11:97\u2013105.","journal-title":"Nat Cell Biol"},{"key":"9058_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.molcel.2012.04.012","volume":"46","author":"SH Min","year":"2012","unstructured":"Min SH, Lau AW, Lee TH, Inuzuka H, Wei S, Huang P, et al. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol Cell. 2012;46:771\u201383.","journal-title":"Mol Cell"},{"key":"9058_CR42","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-024-07117-1","volume":"7","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wu Q, Yang H, Zhang H, Liu C, Yang B, et al. Ferroptosis-related gene signature for predicting prognosis and identifying potential therapeutic drug in EGFR wild-type lung adenocarcinoma. Commun Biol. 2024;7:1416.","journal-title":"Commun Biol"},{"key":"9058_CR43","doi-asserted-by":"crossref","unstructured":"Liu H, Zheng S, Hou G, Dai J, Zhao Y, Yang F, et al. AKAP1\/PKA-mediated GRP75 phosphorylation at mitochondria-associated endoplasmic reticulum membranes protects cancer cells against ferroptosis. Cell Death Differ. 2024;32:88\u2013505.","DOI":"10.1038\/s41418-024-01414-2"},{"key":"9058_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07227-y","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Wei X, Xie Y, Yan Y, Xue S, Wang X, et al. MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21\/GPX4 expression. Cell Death Dis. 2024;15:825.","journal-title":"Cell Death Dis"},{"key":"9058_CR45","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenk\u00e4s K, Bindel N, et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol. 2024;26:1470\u201381.","journal-title":"Nat Cell Biol"},{"key":"9058_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.18632\/aging.204473","volume":"15","author":"H Chen","year":"2023","unstructured":"Chen H, Peng F, Xu J, Wang G, Zhao Y. Increased expression of GPX4 promotes the tumorigenesis of thyroid cancer by inhibiting ferroptosis and predicts poor clinical outcomes. Aging. 2023;15:230\u201345.","journal-title":"Aging"},{"key":"9058_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.31083\/j.fbl2902077","volume":"29","author":"R Hu","year":"2024","unstructured":"Hu R, Shi Z, Yang J, Ren Y, Li X. Anti-ferroptosis: a promising therapeutic method for thyroid cancer. Front Biosci. 2024;29:77.","journal-title":"Front Biosci"},{"key":"9058_CR48","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/tox.23992","volume":"39","author":"F Lian","year":"2024","unstructured":"Lian F, Dong D, Pu J, Yang G, Yang J, Yang S, et al. Ubiquitin-specific peptidase 10 attenuates ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6. Environ Toxicol. 2024;39:1129\u201339.","journal-title":"Environ Toxicol"},{"key":"9058_CR49","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ddr.22059","volume":"84","author":"D Pamarthy","year":"2023","unstructured":"Pamarthy D, Behera SK, Swain S, Yadav S, Suresh S, Jain N, et al. Diaryl ether derivative inhibits GPX4 expression levels to induce ferroptosis in thyroid cancer cells. Drug Dev Res. 2023;84:861\u201387.","journal-title":"Drug Dev Res"},{"key":"9058_CR50","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.18632\/aging.203172","volume":"13","author":"W Chen","year":"2021","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D, et al. Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging. 2021;13:16500\u201312.","journal-title":"Aging"},{"key":"9058_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2015.03.002","volume":"25","author":"MJ Clague","year":"2015","unstructured":"Clague MJ, Heride C, Urb\u00e9 S. The demographics of the ubiquitin system. Trends Cell Biol. 2015;25:417\u201326.","journal-title":"Trends Cell Biol"},{"key":"9058_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-020-0107-0","volume":"5","author":"L Deng","year":"2020","unstructured":"Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5:11.","journal-title":"Signal Transduct Target Ther"},{"key":"9058_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","volume":"26","author":"M Tracz","year":"2021","unstructured":"Tracz M, Bialek W. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol Biol Lett. 2021;26:1.","journal-title":"Cell Mol Biol Lett"},{"key":"9058_CR54","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature07958","volume":"458","author":"M Hochstrasser","year":"2009","unstructured":"Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature. 2009;458:422\u20139.","journal-title":"Nature"},{"key":"9058_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12188","volume":"11","author":"AU Farooq","year":"2022","unstructured":"Farooq AU, Gembus K, Sandow JJ, Webb A, Mathivanan S, Manning JA, et al. K-29 linked ubiquitination of Arrdc4 regulates its function in extracellular vesicle biogenesis. J Extracell Vesicles. 2022;11:e12188.","journal-title":"J Extracell Vesicles"},{"key":"9058_CR56","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41589-021-00823-5","volume":"17","author":"Y Yu","year":"2021","unstructured":"Yu Y, Zheng Q, Erramilli SK, Pan M, Park S, Xie Y, et al. K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle. Nat Chem Biol. 2021;17:896\u2013905.","journal-title":"Nat Chem Biol"},{"key":"9058_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molcel.2015.01.041","volume":"58","author":"YA Kristariyanto","year":"2015","unstructured":"Kristariyanto YA, Abdul Rehman SA, Campbell DG, Morrice NA, Johnson C, Toth R, et al. K29-selective ubiquitin binding domain reveals structural basis of specificity and heterotypic nature of k29 polyubiquitin. Mol Cell. 2015;58:83\u201394.","journal-title":"Mol Cell"},{"key":"9058_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21715-1","volume":"12","author":"YH Chen","year":"2021","unstructured":"Chen YH, Huang TY, Lin YT, Lin SY, Li WH, Hsiao HJ, et al. VPS34 K29\/K48 branched ubiquitination governed by UBE3C and TRABID regulates autophagy, proteostasis and liver metabolism. Nat Commun. 2021;12:1322.","journal-title":"Nat Commun"},{"key":"9058_CR59","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/sj.embor.7400822","volume":"7","author":"P Chastagner","year":"2006","unstructured":"Chastagner P, Isra\u00ebl A, Brou C. Itch\/AIP4 mediates Deltex degradation through the formation of K29-linked polyubiquitin chains. EMBO Rep. 2006;7:1147\u201353.","journal-title":"EMBO Rep"},{"key":"9058_CR60","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211\u2013d7.","journal-title":"Nucleic Acids Res"},{"key":"9058_CR61","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen T, Ma J, Liu Y, Chen Z, Xiao N, Lu Y, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2022;50:D1522\u2013d7.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09058-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09058-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09058-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:45:16Z","timestamp":1789692316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09058-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9058"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09058-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods involving human participants and animals were performed in accordance with the relevant guidelines and regulations. Human thyroid cancer tissues were obtained from the First Affiliated Hospital of Sun Yat-sen University and the Cancer Hospital of Shantou University Medical College. The use of human specimens was approved by the Institutional Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (Approval No. 2019-275) and the Ethics Committee of the Cancer Hospital of Shantou University Medical College (Approval No. 2022093), and written informed consent was obtained from all participants. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Sun Yat-sen University (Approval No. SYSU-IACUC-2021-000647) and performed in accordance with institutional guidelines.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent was obtained from all patients who participated in this study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication was obtained from all participants whose data or images are included in this article.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"815"}}